Furthermore, TGR5 (also known as GPBAR1) was found on infiltrated TAMs, where it affects anti-tumor immunity by contributing to TAM-mediated blockage of CD8+ T cell functions and overall survival in NSCLC patients [527]. This evidence concerns the gene CD8A and non-small cell lung carcinoma.